Global Active Hemostatic Agents Supply, Demand and Key Producers, 2023-2029
The global Active Hemostatic Agents market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Active hemostatic agents are standard surgical techniques to manage bleeding from surgical surfaces. Active hemostatic agents are used in a wide variety of surgical settings, and the evolution of this class of surgical tools helps in the progress of active hemostats into present-day surgery and urology, and highlight opportunities for future research.
This report studies the global Active Hemostatic Agents production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Active Hemostatic Agents, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Active Hemostatic Agents that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Active Hemostatic Agents total production and demand, 2018-2029, (K Units)
Global Active Hemostatic Agents total production value, 2018-2029, (USD Million)
Global Active Hemostatic Agents production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Active Hemostatic Agents consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Active Hemostatic Agents domestic production, consumption, key domestic manufacturers and share
Global Active Hemostatic Agents production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Active Hemostatic Agents production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Active Hemostatic Agents production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Active Hemostatic Agents market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic Plc., Ethicon Inc., Pfizer Inc., Baxter International Inc., CryoLife Inc., Integra Life Sciences Corporation, etc., Stryker, Biom’up and BD, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Active Hemostatic Agents market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Active Hemostatic Agents Market, By Region:
1. How big is the global Active Hemostatic Agents market?
2. What is the demand of the global Active Hemostatic Agents market?
3. What is the year over year growth of the global Active Hemostatic Agents market?
4. What is the production and production value of the global Active Hemostatic Agents market?
5. Who are the key producers in the global Active Hemostatic Agents market?
6. What are the growth factors driving the market demand?
Active hemostatic agents are standard surgical techniques to manage bleeding from surgical surfaces. Active hemostatic agents are used in a wide variety of surgical settings, and the evolution of this class of surgical tools helps in the progress of active hemostats into present-day surgery and urology, and highlight opportunities for future research.
This report studies the global Active Hemostatic Agents production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Active Hemostatic Agents, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Active Hemostatic Agents that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Active Hemostatic Agents total production and demand, 2018-2029, (K Units)
Global Active Hemostatic Agents total production value, 2018-2029, (USD Million)
Global Active Hemostatic Agents production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Active Hemostatic Agents consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Active Hemostatic Agents domestic production, consumption, key domestic manufacturers and share
Global Active Hemostatic Agents production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Active Hemostatic Agents production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Active Hemostatic Agents production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Active Hemostatic Agents market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic Plc., Ethicon Inc., Pfizer Inc., Baxter International Inc., CryoLife Inc., Integra Life Sciences Corporation, etc., Stryker, Biom’up and BD, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Active Hemostatic Agents market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Active Hemostatic Agents Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Thrombin based hemostats
- Surgical Sealants
- Combination Products
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
- Medtronic Plc.
- Ethicon Inc.
- Pfizer Inc.
- Baxter International Inc.
- CryoLife Inc.
- Integra Life Sciences Corporation, etc.
- Stryker
- Biom’up
- BD
- Johnson & Johnson Services
- C.R.Bard
- B. Braun Melsungen AG
- Z-Medica LLC
- Advanced Medical Solutions Group plc
- GELITA GA
- Active Hemostatic Agents
- Warrior Tactical, LLC
1. How big is the global Active Hemostatic Agents market?
2. What is the demand of the global Active Hemostatic Agents market?
3. What is the year over year growth of the global Active Hemostatic Agents market?
4. What is the production and production value of the global Active Hemostatic Agents market?
5. Who are the key producers in the global Active Hemostatic Agents market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Active Hemostatic Agents Introduction
1.2 World Active Hemostatic Agents Supply & Forecast
1.2.1 World Active Hemostatic Agents Production Value (2018 & 2022 & 2029)
1.2.2 World Active Hemostatic Agents Production (2018-2029)
1.2.3 World Active Hemostatic Agents Pricing Trends (2018-2029)
1.3 World Active Hemostatic Agents Production by Region (Based on Production Site)
1.3.1 World Active Hemostatic Agents Production Value by Region (2018-2029)
1.3.2 World Active Hemostatic Agents Production by Region (2018-2029)
1.3.3 World Active Hemostatic Agents Average Price by Region (2018-2029)
1.3.4 North America Active Hemostatic Agents Production (2018-2029)
1.3.5 Europe Active Hemostatic Agents Production (2018-2029)
1.3.6 China Active Hemostatic Agents Production (2018-2029)
1.3.7 Japan Active Hemostatic Agents Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Active Hemostatic Agents Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Active Hemostatic Agents Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Active Hemostatic Agents Demand (2018-2029)
2.2 World Active Hemostatic Agents Consumption by Region
2.2.1 World Active Hemostatic Agents Consumption by Region (2018-2023)
2.2.2 World Active Hemostatic Agents Consumption Forecast by Region (2024-2029)
2.3 United States Active Hemostatic Agents Consumption (2018-2029)
2.4 China Active Hemostatic Agents Consumption (2018-2029)
2.5 Europe Active Hemostatic Agents Consumption (2018-2029)
2.6 Japan Active Hemostatic Agents Consumption (2018-2029)
2.7 South Korea Active Hemostatic Agents Consumption (2018-2029)
2.8 ASEAN Active Hemostatic Agents Consumption (2018-2029)
2.9 India Active Hemostatic Agents Consumption (2018-2029)
3 WORLD ACTIVE HEMOSTATIC AGENTS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Active Hemostatic Agents Production Value by Manufacturer (2018-2023)
3.2 World Active Hemostatic Agents Production by Manufacturer (2018-2023)
3.3 World Active Hemostatic Agents Average Price by Manufacturer (2018-2023)
3.4 Active Hemostatic Agents Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Active Hemostatic Agents Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Active Hemostatic Agents in 2022
3.5.3 Global Concentration Ratios (CR8) for Active Hemostatic Agents in 2022
3.6 Active Hemostatic Agents Market: Overall Company Footprint Analysis
3.6.1 Active Hemostatic Agents Market: Region Footprint
3.6.2 Active Hemostatic Agents Market: Company Product Type Footprint
3.6.3 Active Hemostatic Agents Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Active Hemostatic Agents Production Value Comparison
4.1.1 United States VS China: Active Hemostatic Agents Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Active Hemostatic Agents Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Active Hemostatic Agents Production Comparison
4.2.1 United States VS China: Active Hemostatic Agents Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Active Hemostatic Agents Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Active Hemostatic Agents Consumption Comparison
4.3.1 United States VS China: Active Hemostatic Agents Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Active Hemostatic Agents Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Active Hemostatic Agents Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Active Hemostatic Agents Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Active Hemostatic Agents Production Value (2018-2023)
4.4.3 United States Based Manufacturers Active Hemostatic Agents Production (2018-2023)
4.5 China Based Active Hemostatic Agents Manufacturers and Market Share
4.5.1 China Based Active Hemostatic Agents Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Active Hemostatic Agents Production Value (2018-2023)
4.5.3 China Based Manufacturers Active Hemostatic Agents Production (2018-2023)
4.6 Rest of World Based Active Hemostatic Agents Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Active Hemostatic Agents Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Active Hemostatic Agents Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Active Hemostatic Agents Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Active Hemostatic Agents Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Thrombin based hemostats
5.2.2 Surgical Sealants
5.2.3 Combination Products
5.3 Market Segment by Type
5.3.1 World Active Hemostatic Agents Production by Type (2018-2029)
5.3.2 World Active Hemostatic Agents Production Value by Type (2018-2029)
5.3.3 World Active Hemostatic Agents Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Active Hemostatic Agents Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospitals
6.2.2 Ambulatory Surgical Centers
6.2.3 Specialty Clinics
6.3 Market Segment by Application
6.3.1 World Active Hemostatic Agents Production by Application (2018-2029)
6.3.2 World Active Hemostatic Agents Production Value by Application (2018-2029)
6.3.3 World Active Hemostatic Agents Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Medtronic Plc.
7.1.1 Medtronic Plc. Details
7.1.2 Medtronic Plc. Major Business
7.1.3 Medtronic Plc. Active Hemostatic Agents Product and Services
7.1.4 Medtronic Plc. Active Hemostatic Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Medtronic Plc. Recent Developments/Updates
7.1.6 Medtronic Plc. Competitive Strengths & Weaknesses
7.2 Ethicon Inc.
7.2.1 Ethicon Inc. Details
7.2.2 Ethicon Inc. Major Business
7.2.3 Ethicon Inc. Active Hemostatic Agents Product and Services
7.2.4 Ethicon Inc. Active Hemostatic Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Ethicon Inc. Recent Developments/Updates
7.2.6 Ethicon Inc. Competitive Strengths & Weaknesses
7.3 Pfizer Inc.
7.3.1 Pfizer Inc. Details
7.3.2 Pfizer Inc. Major Business
7.3.3 Pfizer Inc. Active Hemostatic Agents Product and Services
7.3.4 Pfizer Inc. Active Hemostatic Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Pfizer Inc. Recent Developments/Updates
7.3.6 Pfizer Inc. Competitive Strengths & Weaknesses
7.4 Baxter International Inc.
7.4.1 Baxter International Inc. Details
7.4.2 Baxter International Inc. Major Business
7.4.3 Baxter International Inc. Active Hemostatic Agents Product and Services
7.4.4 Baxter International Inc. Active Hemostatic Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Baxter International Inc. Recent Developments/Updates
7.4.6 Baxter International Inc. Competitive Strengths & Weaknesses
7.5 CryoLife Inc.
7.5.1 CryoLife Inc. Details
7.5.2 CryoLife Inc. Major Business
7.5.3 CryoLife Inc. Active Hemostatic Agents Product and Services
7.5.4 CryoLife Inc. Active Hemostatic Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 CryoLife Inc. Recent Developments/Updates
7.5.6 CryoLife Inc. Competitive Strengths & Weaknesses
7.6 Integra Life Sciences Corporation, etc.
7.6.1 Integra Life Sciences Corporation, etc. Details
7.6.2 Integra Life Sciences Corporation, etc. Major Business
7.6.3 Integra Life Sciences Corporation, etc. Active Hemostatic Agents Product and Services
7.6.4 Integra Life Sciences Corporation, etc. Active Hemostatic Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Integra Life Sciences Corporation, etc. Recent Developments/Updates
7.6.6 Integra Life Sciences Corporation, etc. Competitive Strengths & Weaknesses
7.7 Stryker
7.7.1 Stryker Details
7.7.2 Stryker Major Business
7.7.3 Stryker Active Hemostatic Agents Product and Services
7.7.4 Stryker Active Hemostatic Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Stryker Recent Developments/Updates
7.7.6 Stryker Competitive Strengths & Weaknesses
7.8 Biom’up
7.8.1 Biom’up Details
7.8.2 Biom’up Major Business
7.8.3 Biom’up Active Hemostatic Agents Product and Services
7.8.4 Biom’up Active Hemostatic Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Biom’up Recent Developments/Updates
7.8.6 Biom’up Competitive Strengths & Weaknesses
7.9 BD
7.9.1 BD Details
7.9.2 BD Major Business
7.9.3 BD Active Hemostatic Agents Product and Services
7.9.4 BD Active Hemostatic Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 BD Recent Developments/Updates
7.9.6 BD Competitive Strengths & Weaknesses
7.10 Johnson & Johnson Services
7.10.1 Johnson & Johnson Services Details
7.10.2 Johnson & Johnson Services Major Business
7.10.3 Johnson & Johnson Services Active Hemostatic Agents Product and Services
7.10.4 Johnson & Johnson Services Active Hemostatic Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Johnson & Johnson Services Recent Developments/Updates
7.10.6 Johnson & Johnson Services Competitive Strengths & Weaknesses
7.11 C.R.Bard
7.11.1 C.R.Bard Details
7.11.2 C.R.Bard Major Business
7.11.3 C.R.Bard Active Hemostatic Agents Product and Services
7.11.4 C.R.Bard Active Hemostatic Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 C.R.Bard Recent Developments/Updates
7.11.6 C.R.Bard Competitive Strengths & Weaknesses
7.12 B. Braun Melsungen AG
7.12.1 B. Braun Melsungen AG Details
7.12.2 B. Braun Melsungen AG Major Business
7.12.3 B. Braun Melsungen AG Active Hemostatic Agents Product and Services
7.12.4 B. Braun Melsungen AG Active Hemostatic Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 B. Braun Melsungen AG Recent Developments/Updates
7.12.6 B. Braun Melsungen AG Competitive Strengths & Weaknesses
7.13 Z-Medica LLC
7.13.1 Z-Medica LLC Details
7.13.2 Z-Medica LLC Major Business
7.13.3 Z-Medica LLC Active Hemostatic Agents Product and Services
7.13.4 Z-Medica LLC Active Hemostatic Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Z-Medica LLC Recent Developments/Updates
7.13.6 Z-Medica LLC Competitive Strengths & Weaknesses
7.14 Advanced Medical Solutions Group plc
7.14.1 Advanced Medical Solutions Group plc Details
7.14.2 Advanced Medical Solutions Group plc Major Business
7.14.3 Advanced Medical Solutions Group plc Active Hemostatic Agents Product and Services
7.14.4 Advanced Medical Solutions Group plc Active Hemostatic Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Advanced Medical Solutions Group plc Recent Developments/Updates
7.14.6 Advanced Medical Solutions Group plc Competitive Strengths & Weaknesses
7.15 GELITA GA
7.15.1 GELITA GA Details
7.15.2 GELITA GA Major Business
7.15.3 GELITA GA Active Hemostatic Agents Product and Services
7.15.4 GELITA GA Active Hemostatic Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 GELITA GA Recent Developments/Updates
7.15.6 GELITA GA Competitive Strengths & Weaknesses
7.16 Active Hemostatic Agents
7.16.1 Active Hemostatic Agents Details
7.16.2 Active Hemostatic Agents Major Business
7.16.3 Active Hemostatic Agents Active Hemostatic Agents Product and Services
7.16.4 Active Hemostatic Agents Active Hemostatic Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 Active Hemostatic Agents Recent Developments/Updates
7.16.6 Active Hemostatic Agents Competitive Strengths & Weaknesses
7.17 Warrior Tactical, LLC
7.17.1 Warrior Tactical, LLC Details
7.17.2 Warrior Tactical, LLC Major Business
7.17.3 Warrior Tactical, LLC Active Hemostatic Agents Product and Services
7.17.4 Warrior Tactical, LLC Active Hemostatic Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.17.5 Warrior Tactical, LLC Recent Developments/Updates
7.17.6 Warrior Tactical, LLC Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Active Hemostatic Agents Industry Chain
8.2 Active Hemostatic Agents Upstream Analysis
8.2.1 Active Hemostatic Agents Core Raw Materials
8.2.2 Main Manufacturers of Active Hemostatic Agents Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Active Hemostatic Agents Production Mode
8.6 Active Hemostatic Agents Procurement Model
8.7 Active Hemostatic Agents Industry Sales Model and Sales Channels
8.7.1 Active Hemostatic Agents Sales Model
8.7.2 Active Hemostatic Agents Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Active Hemostatic Agents Introduction
1.2 World Active Hemostatic Agents Supply & Forecast
1.2.1 World Active Hemostatic Agents Production Value (2018 & 2022 & 2029)
1.2.2 World Active Hemostatic Agents Production (2018-2029)
1.2.3 World Active Hemostatic Agents Pricing Trends (2018-2029)
1.3 World Active Hemostatic Agents Production by Region (Based on Production Site)
1.3.1 World Active Hemostatic Agents Production Value by Region (2018-2029)
1.3.2 World Active Hemostatic Agents Production by Region (2018-2029)
1.3.3 World Active Hemostatic Agents Average Price by Region (2018-2029)
1.3.4 North America Active Hemostatic Agents Production (2018-2029)
1.3.5 Europe Active Hemostatic Agents Production (2018-2029)
1.3.6 China Active Hemostatic Agents Production (2018-2029)
1.3.7 Japan Active Hemostatic Agents Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Active Hemostatic Agents Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Active Hemostatic Agents Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Active Hemostatic Agents Demand (2018-2029)
2.2 World Active Hemostatic Agents Consumption by Region
2.2.1 World Active Hemostatic Agents Consumption by Region (2018-2023)
2.2.2 World Active Hemostatic Agents Consumption Forecast by Region (2024-2029)
2.3 United States Active Hemostatic Agents Consumption (2018-2029)
2.4 China Active Hemostatic Agents Consumption (2018-2029)
2.5 Europe Active Hemostatic Agents Consumption (2018-2029)
2.6 Japan Active Hemostatic Agents Consumption (2018-2029)
2.7 South Korea Active Hemostatic Agents Consumption (2018-2029)
2.8 ASEAN Active Hemostatic Agents Consumption (2018-2029)
2.9 India Active Hemostatic Agents Consumption (2018-2029)
3 WORLD ACTIVE HEMOSTATIC AGENTS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Active Hemostatic Agents Production Value by Manufacturer (2018-2023)
3.2 World Active Hemostatic Agents Production by Manufacturer (2018-2023)
3.3 World Active Hemostatic Agents Average Price by Manufacturer (2018-2023)
3.4 Active Hemostatic Agents Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Active Hemostatic Agents Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Active Hemostatic Agents in 2022
3.5.3 Global Concentration Ratios (CR8) for Active Hemostatic Agents in 2022
3.6 Active Hemostatic Agents Market: Overall Company Footprint Analysis
3.6.1 Active Hemostatic Agents Market: Region Footprint
3.6.2 Active Hemostatic Agents Market: Company Product Type Footprint
3.6.3 Active Hemostatic Agents Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Active Hemostatic Agents Production Value Comparison
4.1.1 United States VS China: Active Hemostatic Agents Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Active Hemostatic Agents Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Active Hemostatic Agents Production Comparison
4.2.1 United States VS China: Active Hemostatic Agents Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Active Hemostatic Agents Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Active Hemostatic Agents Consumption Comparison
4.3.1 United States VS China: Active Hemostatic Agents Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Active Hemostatic Agents Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Active Hemostatic Agents Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Active Hemostatic Agents Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Active Hemostatic Agents Production Value (2018-2023)
4.4.3 United States Based Manufacturers Active Hemostatic Agents Production (2018-2023)
4.5 China Based Active Hemostatic Agents Manufacturers and Market Share
4.5.1 China Based Active Hemostatic Agents Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Active Hemostatic Agents Production Value (2018-2023)
4.5.3 China Based Manufacturers Active Hemostatic Agents Production (2018-2023)
4.6 Rest of World Based Active Hemostatic Agents Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Active Hemostatic Agents Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Active Hemostatic Agents Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Active Hemostatic Agents Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Active Hemostatic Agents Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Thrombin based hemostats
5.2.2 Surgical Sealants
5.2.3 Combination Products
5.3 Market Segment by Type
5.3.1 World Active Hemostatic Agents Production by Type (2018-2029)
5.3.2 World Active Hemostatic Agents Production Value by Type (2018-2029)
5.3.3 World Active Hemostatic Agents Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Active Hemostatic Agents Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospitals
6.2.2 Ambulatory Surgical Centers
6.2.3 Specialty Clinics
6.3 Market Segment by Application
6.3.1 World Active Hemostatic Agents Production by Application (2018-2029)
6.3.2 World Active Hemostatic Agents Production Value by Application (2018-2029)
6.3.3 World Active Hemostatic Agents Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Medtronic Plc.
7.1.1 Medtronic Plc. Details
7.1.2 Medtronic Plc. Major Business
7.1.3 Medtronic Plc. Active Hemostatic Agents Product and Services
7.1.4 Medtronic Plc. Active Hemostatic Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Medtronic Plc. Recent Developments/Updates
7.1.6 Medtronic Plc. Competitive Strengths & Weaknesses
7.2 Ethicon Inc.
7.2.1 Ethicon Inc. Details
7.2.2 Ethicon Inc. Major Business
7.2.3 Ethicon Inc. Active Hemostatic Agents Product and Services
7.2.4 Ethicon Inc. Active Hemostatic Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Ethicon Inc. Recent Developments/Updates
7.2.6 Ethicon Inc. Competitive Strengths & Weaknesses
7.3 Pfizer Inc.
7.3.1 Pfizer Inc. Details
7.3.2 Pfizer Inc. Major Business
7.3.3 Pfizer Inc. Active Hemostatic Agents Product and Services
7.3.4 Pfizer Inc. Active Hemostatic Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Pfizer Inc. Recent Developments/Updates
7.3.6 Pfizer Inc. Competitive Strengths & Weaknesses
7.4 Baxter International Inc.
7.4.1 Baxter International Inc. Details
7.4.2 Baxter International Inc. Major Business
7.4.3 Baxter International Inc. Active Hemostatic Agents Product and Services
7.4.4 Baxter International Inc. Active Hemostatic Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Baxter International Inc. Recent Developments/Updates
7.4.6 Baxter International Inc. Competitive Strengths & Weaknesses
7.5 CryoLife Inc.
7.5.1 CryoLife Inc. Details
7.5.2 CryoLife Inc. Major Business
7.5.3 CryoLife Inc. Active Hemostatic Agents Product and Services
7.5.4 CryoLife Inc. Active Hemostatic Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 CryoLife Inc. Recent Developments/Updates
7.5.6 CryoLife Inc. Competitive Strengths & Weaknesses
7.6 Integra Life Sciences Corporation, etc.
7.6.1 Integra Life Sciences Corporation, etc. Details
7.6.2 Integra Life Sciences Corporation, etc. Major Business
7.6.3 Integra Life Sciences Corporation, etc. Active Hemostatic Agents Product and Services
7.6.4 Integra Life Sciences Corporation, etc. Active Hemostatic Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Integra Life Sciences Corporation, etc. Recent Developments/Updates
7.6.6 Integra Life Sciences Corporation, etc. Competitive Strengths & Weaknesses
7.7 Stryker
7.7.1 Stryker Details
7.7.2 Stryker Major Business
7.7.3 Stryker Active Hemostatic Agents Product and Services
7.7.4 Stryker Active Hemostatic Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Stryker Recent Developments/Updates
7.7.6 Stryker Competitive Strengths & Weaknesses
7.8 Biom’up
7.8.1 Biom’up Details
7.8.2 Biom’up Major Business
7.8.3 Biom’up Active Hemostatic Agents Product and Services
7.8.4 Biom’up Active Hemostatic Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Biom’up Recent Developments/Updates
7.8.6 Biom’up Competitive Strengths & Weaknesses
7.9 BD
7.9.1 BD Details
7.9.2 BD Major Business
7.9.3 BD Active Hemostatic Agents Product and Services
7.9.4 BD Active Hemostatic Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 BD Recent Developments/Updates
7.9.6 BD Competitive Strengths & Weaknesses
7.10 Johnson & Johnson Services
7.10.1 Johnson & Johnson Services Details
7.10.2 Johnson & Johnson Services Major Business
7.10.3 Johnson & Johnson Services Active Hemostatic Agents Product and Services
7.10.4 Johnson & Johnson Services Active Hemostatic Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Johnson & Johnson Services Recent Developments/Updates
7.10.6 Johnson & Johnson Services Competitive Strengths & Weaknesses
7.11 C.R.Bard
7.11.1 C.R.Bard Details
7.11.2 C.R.Bard Major Business
7.11.3 C.R.Bard Active Hemostatic Agents Product and Services
7.11.4 C.R.Bard Active Hemostatic Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 C.R.Bard Recent Developments/Updates
7.11.6 C.R.Bard Competitive Strengths & Weaknesses
7.12 B. Braun Melsungen AG
7.12.1 B. Braun Melsungen AG Details
7.12.2 B. Braun Melsungen AG Major Business
7.12.3 B. Braun Melsungen AG Active Hemostatic Agents Product and Services
7.12.4 B. Braun Melsungen AG Active Hemostatic Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 B. Braun Melsungen AG Recent Developments/Updates
7.12.6 B. Braun Melsungen AG Competitive Strengths & Weaknesses
7.13 Z-Medica LLC
7.13.1 Z-Medica LLC Details
7.13.2 Z-Medica LLC Major Business
7.13.3 Z-Medica LLC Active Hemostatic Agents Product and Services
7.13.4 Z-Medica LLC Active Hemostatic Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Z-Medica LLC Recent Developments/Updates
7.13.6 Z-Medica LLC Competitive Strengths & Weaknesses
7.14 Advanced Medical Solutions Group plc
7.14.1 Advanced Medical Solutions Group plc Details
7.14.2 Advanced Medical Solutions Group plc Major Business
7.14.3 Advanced Medical Solutions Group plc Active Hemostatic Agents Product and Services
7.14.4 Advanced Medical Solutions Group plc Active Hemostatic Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Advanced Medical Solutions Group plc Recent Developments/Updates
7.14.6 Advanced Medical Solutions Group plc Competitive Strengths & Weaknesses
7.15 GELITA GA
7.15.1 GELITA GA Details
7.15.2 GELITA GA Major Business
7.15.3 GELITA GA Active Hemostatic Agents Product and Services
7.15.4 GELITA GA Active Hemostatic Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 GELITA GA Recent Developments/Updates
7.15.6 GELITA GA Competitive Strengths & Weaknesses
7.16 Active Hemostatic Agents
7.16.1 Active Hemostatic Agents Details
7.16.2 Active Hemostatic Agents Major Business
7.16.3 Active Hemostatic Agents Active Hemostatic Agents Product and Services
7.16.4 Active Hemostatic Agents Active Hemostatic Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 Active Hemostatic Agents Recent Developments/Updates
7.16.6 Active Hemostatic Agents Competitive Strengths & Weaknesses
7.17 Warrior Tactical, LLC
7.17.1 Warrior Tactical, LLC Details
7.17.2 Warrior Tactical, LLC Major Business
7.17.3 Warrior Tactical, LLC Active Hemostatic Agents Product and Services
7.17.4 Warrior Tactical, LLC Active Hemostatic Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.17.5 Warrior Tactical, LLC Recent Developments/Updates
7.17.6 Warrior Tactical, LLC Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Active Hemostatic Agents Industry Chain
8.2 Active Hemostatic Agents Upstream Analysis
8.2.1 Active Hemostatic Agents Core Raw Materials
8.2.2 Main Manufacturers of Active Hemostatic Agents Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Active Hemostatic Agents Production Mode
8.6 Active Hemostatic Agents Procurement Model
8.7 Active Hemostatic Agents Industry Sales Model and Sales Channels
8.7.1 Active Hemostatic Agents Sales Model
8.7.2 Active Hemostatic Agents Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Active Hemostatic Agents Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Active Hemostatic Agents Production Value by Region (2018-2023) & (USD Million)
Table 3. World Active Hemostatic Agents Production Value by Region (2024-2029) & (USD Million)
Table 4. World Active Hemostatic Agents Production Value Market Share by Region (2018-2023)
Table 5. World Active Hemostatic Agents Production Value Market Share by Region (2024-2029)
Table 6. World Active Hemostatic Agents Production by Region (2018-2023) & (K Units)
Table 7. World Active Hemostatic Agents Production by Region (2024-2029) & (K Units)
Table 8. World Active Hemostatic Agents Production Market Share by Region (2018-2023)
Table 9. World Active Hemostatic Agents Production Market Share by Region (2024-2029)
Table 10. World Active Hemostatic Agents Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Active Hemostatic Agents Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Active Hemostatic Agents Major Market Trends
Table 13. World Active Hemostatic Agents Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Active Hemostatic Agents Consumption by Region (2018-2023) & (K Units)
Table 15. World Active Hemostatic Agents Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Active Hemostatic Agents Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Active Hemostatic Agents Producers in 2022
Table 18. World Active Hemostatic Agents Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Active Hemostatic Agents Producers in 2022
Table 20. World Active Hemostatic Agents Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Active Hemostatic Agents Company Evaluation Quadrant
Table 22. World Active Hemostatic Agents Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Active Hemostatic Agents Production Site of Key Manufacturer
Table 24. Active Hemostatic Agents Market: Company Product Type Footprint
Table 25. Active Hemostatic Agents Market: Company Product Application Footprint
Table 26. Active Hemostatic Agents Competitive Factors
Table 27. Active Hemostatic Agents New Entrant and Capacity Expansion Plans
Table 28. Active Hemostatic Agents Mergers & Acquisitions Activity
Table 29. United States VS China Active Hemostatic Agents Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Active Hemostatic Agents Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Active Hemostatic Agents Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Active Hemostatic Agents Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Active Hemostatic Agents Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Active Hemostatic Agents Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Active Hemostatic Agents Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Active Hemostatic Agents Production Market Share (2018-2023)
Table 37. China Based Active Hemostatic Agents Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Active Hemostatic Agents Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Active Hemostatic Agents Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Active Hemostatic Agents Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Active Hemostatic Agents Production Market Share (2018-2023)
Table 42. Rest of World Based Active Hemostatic Agents Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Active Hemostatic Agents Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Active Hemostatic Agents Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Active Hemostatic Agents Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Active Hemostatic Agents Production Market Share (2018-2023)
Table 47. World Active Hemostatic Agents Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Active Hemostatic Agents Production by Type (2018-2023) & (K Units)
Table 49. World Active Hemostatic Agents Production by Type (2024-2029) & (K Units)
Table 50. World Active Hemostatic Agents Production Value by Type (2018-2023) & (USD Million)
Table 51. World Active Hemostatic Agents Production Value by Type (2024-2029) & (USD Million)
Table 52. World Active Hemostatic Agents Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Active Hemostatic Agents Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Active Hemostatic Agents Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Active Hemostatic Agents Production by Application (2018-2023) & (K Units)
Table 56. World Active Hemostatic Agents Production by Application (2024-2029) & (K Units)
Table 57. World Active Hemostatic Agents Production Value by Application (2018-2023) & (USD Million)
Table 58. World Active Hemostatic Agents Production Value by Application (2024-2029) & (USD Million)
Table 59. World Active Hemostatic Agents Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Active Hemostatic Agents Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Medtronic Plc. Basic Information, Manufacturing Base and Competitors
Table 62. Medtronic Plc. Major Business
Table 63. Medtronic Plc. Active Hemostatic Agents Product and Services
Table 64. Medtronic Plc. Active Hemostatic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Medtronic Plc. Recent Developments/Updates
Table 66. Medtronic Plc. Competitive Strengths & Weaknesses
Table 67. Ethicon Inc. Basic Information, Manufacturing Base and Competitors
Table 68. Ethicon Inc. Major Business
Table 69. Ethicon Inc. Active Hemostatic Agents Product and Services
Table 70. Ethicon Inc. Active Hemostatic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Ethicon Inc. Recent Developments/Updates
Table 72. Ethicon Inc. Competitive Strengths & Weaknesses
Table 73. Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table 74. Pfizer Inc. Major Business
Table 75. Pfizer Inc. Active Hemostatic Agents Product and Services
Table 76. Pfizer Inc. Active Hemostatic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Pfizer Inc. Recent Developments/Updates
Table 78. Pfizer Inc. Competitive Strengths & Weaknesses
Table 79. Baxter International Inc. Basic Information, Manufacturing Base and Competitors
Table 80. Baxter International Inc. Major Business
Table 81. Baxter International Inc. Active Hemostatic Agents Product and Services
Table 82. Baxter International Inc. Active Hemostatic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Baxter International Inc. Recent Developments/Updates
Table 84. Baxter International Inc. Competitive Strengths & Weaknesses
Table 85. CryoLife Inc. Basic Information, Manufacturing Base and Competitors
Table 86. CryoLife Inc. Major Business
Table 87. CryoLife Inc. Active Hemostatic Agents Product and Services
Table 88. CryoLife Inc. Active Hemostatic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. CryoLife Inc. Recent Developments/Updates
Table 90. CryoLife Inc. Competitive Strengths & Weaknesses
Table 91. Integra Life Sciences Corporation, etc. Basic Information, Manufacturing Base and Competitors
Table 92. Integra Life Sciences Corporation, etc. Major Business
Table 93. Integra Life Sciences Corporation, etc. Active Hemostatic Agents Product and Services
Table 94. Integra Life Sciences Corporation, etc. Active Hemostatic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Integra Life Sciences Corporation, etc. Recent Developments/Updates
Table 96. Integra Life Sciences Corporation, etc. Competitive Strengths & Weaknesses
Table 97. Stryker Basic Information, Manufacturing Base and Competitors
Table 98. Stryker Major Business
Table 99. Stryker Active Hemostatic Agents Product and Services
Table 100. Stryker Active Hemostatic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Stryker Recent Developments/Updates
Table 102. Stryker Competitive Strengths & Weaknesses
Table 103. Biom’up Basic Information, Manufacturing Base and Competitors
Table 104. Biom’up Major Business
Table 105. Biom’up Active Hemostatic Agents Product and Services
Table 106. Biom’up Active Hemostatic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Biom’up Recent Developments/Updates
Table 108. Biom’up Competitive Strengths & Weaknesses
Table 109. BD Basic Information, Manufacturing Base and Competitors
Table 110. BD Major Business
Table 111. BD Active Hemostatic Agents Product and Services
Table 112. BD Active Hemostatic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. BD Recent Developments/Updates
Table 114. BD Competitive Strengths & Weaknesses
Table 115. Johnson & Johnson Services Basic Information, Manufacturing Base and Competitors
Table 116. Johnson & Johnson Services Major Business
Table 117. Johnson & Johnson Services Active Hemostatic Agents Product and Services
Table 118. Johnson & Johnson Services Active Hemostatic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Johnson & Johnson Services Recent Developments/Updates
Table 120. Johnson & Johnson Services Competitive Strengths & Weaknesses
Table 121. C.R.Bard Basic Information, Manufacturing Base and Competitors
Table 122. C.R.Bard Major Business
Table 123. C.R.Bard Active Hemostatic Agents Product and Services
Table 124. C.R.Bard Active Hemostatic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. C.R.Bard Recent Developments/Updates
Table 126. C.R.Bard Competitive Strengths & Weaknesses
Table 127. B. Braun Melsungen AG Basic Information, Manufacturing Base and Competitors
Table 128. B. Braun Melsungen AG Major Business
Table 129. B. Braun Melsungen AG Active Hemostatic Agents Product and Services
Table 130. B. Braun Melsungen AG Active Hemostatic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. B. Braun Melsungen AG Recent Developments/Updates
Table 132. B. Braun Melsungen AG Competitive Strengths & Weaknesses
Table 133. Z-Medica LLC Basic Information, Manufacturing Base and Competitors
Table 134. Z-Medica LLC Major Business
Table 135. Z-Medica LLC Active Hemostatic Agents Product and Services
Table 136. Z-Medica LLC Active Hemostatic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Z-Medica LLC Recent Developments/Updates
Table 138. Z-Medica LLC Competitive Strengths & Weaknesses
Table 139. Advanced Medical Solutions Group plc Basic Information, Manufacturing Base and Competitors
Table 140. Advanced Medical Solutions Group plc Major Business
Table 141. Advanced Medical Solutions Group plc Active Hemostatic Agents Product and Services
Table 142. Advanced Medical Solutions Group plc Active Hemostatic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Advanced Medical Solutions Group plc Recent Developments/Updates
Table 144. Advanced Medical Solutions Group plc Competitive Strengths & Weaknesses
Table 145. GELITA GA Basic Information, Manufacturing Base and Competitors
Table 146. GELITA GA Major Business
Table 147. GELITA GA Active Hemostatic Agents Product and Services
Table 148. GELITA GA Active Hemostatic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. GELITA GA Recent Developments/Updates
Table 150. GELITA GA Competitive Strengths & Weaknesses
Table 151. Active Hemostatic Agents Basic Information, Manufacturing Base and Competitors
Table 152. Active Hemostatic Agents Major Business
Table 153. Active Hemostatic Agents Active Hemostatic Agents Product and Services
Table 154. Active Hemostatic Agents Active Hemostatic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 155. Active Hemostatic Agents Recent Developments/Updates
Table 156. Warrior Tactical, LLC Basic Information, Manufacturing Base and Competitors
Table 157. Warrior Tactical, LLC Major Business
Table 158. Warrior Tactical, LLC Active Hemostatic Agents Product and Services
Table 159. Warrior Tactical, LLC Active Hemostatic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 160. Global Key Players of Active Hemostatic Agents Upstream (Raw Materials)
Table 161. Active Hemostatic Agents Typical Customers
Table 162. Active Hemostatic Agents Typical Distributors
Table 1. World Active Hemostatic Agents Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Active Hemostatic Agents Production Value by Region (2018-2023) & (USD Million)
Table 3. World Active Hemostatic Agents Production Value by Region (2024-2029) & (USD Million)
Table 4. World Active Hemostatic Agents Production Value Market Share by Region (2018-2023)
Table 5. World Active Hemostatic Agents Production Value Market Share by Region (2024-2029)
Table 6. World Active Hemostatic Agents Production by Region (2018-2023) & (K Units)
Table 7. World Active Hemostatic Agents Production by Region (2024-2029) & (K Units)
Table 8. World Active Hemostatic Agents Production Market Share by Region (2018-2023)
Table 9. World Active Hemostatic Agents Production Market Share by Region (2024-2029)
Table 10. World Active Hemostatic Agents Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Active Hemostatic Agents Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Active Hemostatic Agents Major Market Trends
Table 13. World Active Hemostatic Agents Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Active Hemostatic Agents Consumption by Region (2018-2023) & (K Units)
Table 15. World Active Hemostatic Agents Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Active Hemostatic Agents Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Active Hemostatic Agents Producers in 2022
Table 18. World Active Hemostatic Agents Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Active Hemostatic Agents Producers in 2022
Table 20. World Active Hemostatic Agents Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Active Hemostatic Agents Company Evaluation Quadrant
Table 22. World Active Hemostatic Agents Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Active Hemostatic Agents Production Site of Key Manufacturer
Table 24. Active Hemostatic Agents Market: Company Product Type Footprint
Table 25. Active Hemostatic Agents Market: Company Product Application Footprint
Table 26. Active Hemostatic Agents Competitive Factors
Table 27. Active Hemostatic Agents New Entrant and Capacity Expansion Plans
Table 28. Active Hemostatic Agents Mergers & Acquisitions Activity
Table 29. United States VS China Active Hemostatic Agents Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Active Hemostatic Agents Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Active Hemostatic Agents Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Active Hemostatic Agents Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Active Hemostatic Agents Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Active Hemostatic Agents Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Active Hemostatic Agents Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Active Hemostatic Agents Production Market Share (2018-2023)
Table 37. China Based Active Hemostatic Agents Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Active Hemostatic Agents Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Active Hemostatic Agents Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Active Hemostatic Agents Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Active Hemostatic Agents Production Market Share (2018-2023)
Table 42. Rest of World Based Active Hemostatic Agents Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Active Hemostatic Agents Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Active Hemostatic Agents Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Active Hemostatic Agents Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Active Hemostatic Agents Production Market Share (2018-2023)
Table 47. World Active Hemostatic Agents Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Active Hemostatic Agents Production by Type (2018-2023) & (K Units)
Table 49. World Active Hemostatic Agents Production by Type (2024-2029) & (K Units)
Table 50. World Active Hemostatic Agents Production Value by Type (2018-2023) & (USD Million)
Table 51. World Active Hemostatic Agents Production Value by Type (2024-2029) & (USD Million)
Table 52. World Active Hemostatic Agents Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Active Hemostatic Agents Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Active Hemostatic Agents Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Active Hemostatic Agents Production by Application (2018-2023) & (K Units)
Table 56. World Active Hemostatic Agents Production by Application (2024-2029) & (K Units)
Table 57. World Active Hemostatic Agents Production Value by Application (2018-2023) & (USD Million)
Table 58. World Active Hemostatic Agents Production Value by Application (2024-2029) & (USD Million)
Table 59. World Active Hemostatic Agents Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Active Hemostatic Agents Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Medtronic Plc. Basic Information, Manufacturing Base and Competitors
Table 62. Medtronic Plc. Major Business
Table 63. Medtronic Plc. Active Hemostatic Agents Product and Services
Table 64. Medtronic Plc. Active Hemostatic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Medtronic Plc. Recent Developments/Updates
Table 66. Medtronic Plc. Competitive Strengths & Weaknesses
Table 67. Ethicon Inc. Basic Information, Manufacturing Base and Competitors
Table 68. Ethicon Inc. Major Business
Table 69. Ethicon Inc. Active Hemostatic Agents Product and Services
Table 70. Ethicon Inc. Active Hemostatic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Ethicon Inc. Recent Developments/Updates
Table 72. Ethicon Inc. Competitive Strengths & Weaknesses
Table 73. Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table 74. Pfizer Inc. Major Business
Table 75. Pfizer Inc. Active Hemostatic Agents Product and Services
Table 76. Pfizer Inc. Active Hemostatic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Pfizer Inc. Recent Developments/Updates
Table 78. Pfizer Inc. Competitive Strengths & Weaknesses
Table 79. Baxter International Inc. Basic Information, Manufacturing Base and Competitors
Table 80. Baxter International Inc. Major Business
Table 81. Baxter International Inc. Active Hemostatic Agents Product and Services
Table 82. Baxter International Inc. Active Hemostatic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Baxter International Inc. Recent Developments/Updates
Table 84. Baxter International Inc. Competitive Strengths & Weaknesses
Table 85. CryoLife Inc. Basic Information, Manufacturing Base and Competitors
Table 86. CryoLife Inc. Major Business
Table 87. CryoLife Inc. Active Hemostatic Agents Product and Services
Table 88. CryoLife Inc. Active Hemostatic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. CryoLife Inc. Recent Developments/Updates
Table 90. CryoLife Inc. Competitive Strengths & Weaknesses
Table 91. Integra Life Sciences Corporation, etc. Basic Information, Manufacturing Base and Competitors
Table 92. Integra Life Sciences Corporation, etc. Major Business
Table 93. Integra Life Sciences Corporation, etc. Active Hemostatic Agents Product and Services
Table 94. Integra Life Sciences Corporation, etc. Active Hemostatic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Integra Life Sciences Corporation, etc. Recent Developments/Updates
Table 96. Integra Life Sciences Corporation, etc. Competitive Strengths & Weaknesses
Table 97. Stryker Basic Information, Manufacturing Base and Competitors
Table 98. Stryker Major Business
Table 99. Stryker Active Hemostatic Agents Product and Services
Table 100. Stryker Active Hemostatic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Stryker Recent Developments/Updates
Table 102. Stryker Competitive Strengths & Weaknesses
Table 103. Biom’up Basic Information, Manufacturing Base and Competitors
Table 104. Biom’up Major Business
Table 105. Biom’up Active Hemostatic Agents Product and Services
Table 106. Biom’up Active Hemostatic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Biom’up Recent Developments/Updates
Table 108. Biom’up Competitive Strengths & Weaknesses
Table 109. BD Basic Information, Manufacturing Base and Competitors
Table 110. BD Major Business
Table 111. BD Active Hemostatic Agents Product and Services
Table 112. BD Active Hemostatic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. BD Recent Developments/Updates
Table 114. BD Competitive Strengths & Weaknesses
Table 115. Johnson & Johnson Services Basic Information, Manufacturing Base and Competitors
Table 116. Johnson & Johnson Services Major Business
Table 117. Johnson & Johnson Services Active Hemostatic Agents Product and Services
Table 118. Johnson & Johnson Services Active Hemostatic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Johnson & Johnson Services Recent Developments/Updates
Table 120. Johnson & Johnson Services Competitive Strengths & Weaknesses
Table 121. C.R.Bard Basic Information, Manufacturing Base and Competitors
Table 122. C.R.Bard Major Business
Table 123. C.R.Bard Active Hemostatic Agents Product and Services
Table 124. C.R.Bard Active Hemostatic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. C.R.Bard Recent Developments/Updates
Table 126. C.R.Bard Competitive Strengths & Weaknesses
Table 127. B. Braun Melsungen AG Basic Information, Manufacturing Base and Competitors
Table 128. B. Braun Melsungen AG Major Business
Table 129. B. Braun Melsungen AG Active Hemostatic Agents Product and Services
Table 130. B. Braun Melsungen AG Active Hemostatic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. B. Braun Melsungen AG Recent Developments/Updates
Table 132. B. Braun Melsungen AG Competitive Strengths & Weaknesses
Table 133. Z-Medica LLC Basic Information, Manufacturing Base and Competitors
Table 134. Z-Medica LLC Major Business
Table 135. Z-Medica LLC Active Hemostatic Agents Product and Services
Table 136. Z-Medica LLC Active Hemostatic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Z-Medica LLC Recent Developments/Updates
Table 138. Z-Medica LLC Competitive Strengths & Weaknesses
Table 139. Advanced Medical Solutions Group plc Basic Information, Manufacturing Base and Competitors
Table 140. Advanced Medical Solutions Group plc Major Business
Table 141. Advanced Medical Solutions Group plc Active Hemostatic Agents Product and Services
Table 142. Advanced Medical Solutions Group plc Active Hemostatic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Advanced Medical Solutions Group plc Recent Developments/Updates
Table 144. Advanced Medical Solutions Group plc Competitive Strengths & Weaknesses
Table 145. GELITA GA Basic Information, Manufacturing Base and Competitors
Table 146. GELITA GA Major Business
Table 147. GELITA GA Active Hemostatic Agents Product and Services
Table 148. GELITA GA Active Hemostatic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. GELITA GA Recent Developments/Updates
Table 150. GELITA GA Competitive Strengths & Weaknesses
Table 151. Active Hemostatic Agents Basic Information, Manufacturing Base and Competitors
Table 152. Active Hemostatic Agents Major Business
Table 153. Active Hemostatic Agents Active Hemostatic Agents Product and Services
Table 154. Active Hemostatic Agents Active Hemostatic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 155. Active Hemostatic Agents Recent Developments/Updates
Table 156. Warrior Tactical, LLC Basic Information, Manufacturing Base and Competitors
Table 157. Warrior Tactical, LLC Major Business
Table 158. Warrior Tactical, LLC Active Hemostatic Agents Product and Services
Table 159. Warrior Tactical, LLC Active Hemostatic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 160. Global Key Players of Active Hemostatic Agents Upstream (Raw Materials)
Table 161. Active Hemostatic Agents Typical Customers
Table 162. Active Hemostatic Agents Typical Distributors
LIST OF FIGURES
Figure 1. Active Hemostatic Agents Picture
Figure 2. World Active Hemostatic Agents Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Active Hemostatic Agents Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Active Hemostatic Agents Production (2018-2029) & (K Units)
Figure 5. World Active Hemostatic Agents Average Price (2018-2029) & (US$/Unit)
Figure 6. World Active Hemostatic Agents Production Value Market Share by Region (2018-2029)
Figure 7. World Active Hemostatic Agents Production Market Share by Region (2018-2029)
Figure 8. North America Active Hemostatic Agents Production (2018-2029) & (K Units)
Figure 9. Europe Active Hemostatic Agents Production (2018-2029) & (K Units)
Figure 10. China Active Hemostatic Agents Production (2018-2029) & (K Units)
Figure 11. Japan Active Hemostatic Agents Production (2018-2029) & (K Units)
Figure 12. Active Hemostatic Agents Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Active Hemostatic Agents Consumption (2018-2029) & (K Units)
Figure 15. World Active Hemostatic Agents Consumption Market Share by Region (2018-2029)
Figure 16. United States Active Hemostatic Agents Consumption (2018-2029) & (K Units)
Figure 17. China Active Hemostatic Agents Consumption (2018-2029) & (K Units)
Figure 18. Europe Active Hemostatic Agents Consumption (2018-2029) & (K Units)
Figure 19. Japan Active Hemostatic Agents Consumption (2018-2029) & (K Units)
Figure 20. South Korea Active Hemostatic Agents Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Active Hemostatic Agents Consumption (2018-2029) & (K Units)
Figure 22. India Active Hemostatic Agents Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Active Hemostatic Agents by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Active Hemostatic Agents Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Active Hemostatic Agents Markets in 2022
Figure 26. United States VS China: Active Hemostatic Agents Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Active Hemostatic Agents Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Active Hemostatic Agents Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Active Hemostatic Agents Production Market Share 2022
Figure 30. China Based Manufacturers Active Hemostatic Agents Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Active Hemostatic Agents Production Market Share 2022
Figure 32. World Active Hemostatic Agents Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Active Hemostatic Agents Production Value Market Share by Type in 2022
Figure 34. Thrombin based hemostats
Figure 35. Surgical Sealants
Figure 36. Combination Products
Figure 37. World Active Hemostatic Agents Production Market Share by Type (2018-2029)
Figure 38. World Active Hemostatic Agents Production Value Market Share by Type (2018-2029)
Figure 39. World Active Hemostatic Agents Average Price by Type (2018-2029) & (US$/Unit)
Figure 40. World Active Hemostatic Agents Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World Active Hemostatic Agents Production Value Market Share by Application in 2022
Figure 42. Hospitals
Figure 43. Ambulatory Surgical Centers
Figure 44. Specialty Clinics
Figure 45. World Active Hemostatic Agents Production Market Share by Application (2018-2029)
Figure 46. World Active Hemostatic Agents Production Value Market Share by Application (2018-2029)
Figure 47. World Active Hemostatic Agents Average Price by Application (2018-2029) & (US$/Unit)
Figure 48. Active Hemostatic Agents Industry Chain
Figure 49. Active Hemostatic Agents Procurement Model
Figure 50. Active Hemostatic Agents Sales Model
Figure 51. Active Hemostatic Agents Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source
Figure 1. Active Hemostatic Agents Picture
Figure 2. World Active Hemostatic Agents Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Active Hemostatic Agents Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Active Hemostatic Agents Production (2018-2029) & (K Units)
Figure 5. World Active Hemostatic Agents Average Price (2018-2029) & (US$/Unit)
Figure 6. World Active Hemostatic Agents Production Value Market Share by Region (2018-2029)
Figure 7. World Active Hemostatic Agents Production Market Share by Region (2018-2029)
Figure 8. North America Active Hemostatic Agents Production (2018-2029) & (K Units)
Figure 9. Europe Active Hemostatic Agents Production (2018-2029) & (K Units)
Figure 10. China Active Hemostatic Agents Production (2018-2029) & (K Units)
Figure 11. Japan Active Hemostatic Agents Production (2018-2029) & (K Units)
Figure 12. Active Hemostatic Agents Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Active Hemostatic Agents Consumption (2018-2029) & (K Units)
Figure 15. World Active Hemostatic Agents Consumption Market Share by Region (2018-2029)
Figure 16. United States Active Hemostatic Agents Consumption (2018-2029) & (K Units)
Figure 17. China Active Hemostatic Agents Consumption (2018-2029) & (K Units)
Figure 18. Europe Active Hemostatic Agents Consumption (2018-2029) & (K Units)
Figure 19. Japan Active Hemostatic Agents Consumption (2018-2029) & (K Units)
Figure 20. South Korea Active Hemostatic Agents Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Active Hemostatic Agents Consumption (2018-2029) & (K Units)
Figure 22. India Active Hemostatic Agents Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Active Hemostatic Agents by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Active Hemostatic Agents Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Active Hemostatic Agents Markets in 2022
Figure 26. United States VS China: Active Hemostatic Agents Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Active Hemostatic Agents Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Active Hemostatic Agents Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Active Hemostatic Agents Production Market Share 2022
Figure 30. China Based Manufacturers Active Hemostatic Agents Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Active Hemostatic Agents Production Market Share 2022
Figure 32. World Active Hemostatic Agents Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Active Hemostatic Agents Production Value Market Share by Type in 2022
Figure 34. Thrombin based hemostats
Figure 35. Surgical Sealants
Figure 36. Combination Products
Figure 37. World Active Hemostatic Agents Production Market Share by Type (2018-2029)
Figure 38. World Active Hemostatic Agents Production Value Market Share by Type (2018-2029)
Figure 39. World Active Hemostatic Agents Average Price by Type (2018-2029) & (US$/Unit)
Figure 40. World Active Hemostatic Agents Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World Active Hemostatic Agents Production Value Market Share by Application in 2022
Figure 42. Hospitals
Figure 43. Ambulatory Surgical Centers
Figure 44. Specialty Clinics
Figure 45. World Active Hemostatic Agents Production Market Share by Application (2018-2029)
Figure 46. World Active Hemostatic Agents Production Value Market Share by Application (2018-2029)
Figure 47. World Active Hemostatic Agents Average Price by Application (2018-2029) & (US$/Unit)
Figure 48. Active Hemostatic Agents Industry Chain
Figure 49. Active Hemostatic Agents Procurement Model
Figure 50. Active Hemostatic Agents Sales Model
Figure 51. Active Hemostatic Agents Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source
